No Insurance Required!
Click to Sign Up Today
Your privacy is important to us. By completing the following pre-screener you agree to our Privacy Policy and Terms of Use, and agree that we may retain the personal information you provide and share it with personnel involved in the study, or otherwise as described in the Privacy Policy, and we or our affiliates may contact you by phone using automated technology or pre-recorded voicemail or other means including but not limited to text messages (standard messaging rates may apply) regarding research studies.
At Elixia, we are dedicated to advancing medical research and improving lives through innovative clinical studies. Our mission is to develop groundbreaking treatments for respiratory disorders, including asthma, to enhance patient outcomes and improve quality of life.
Join the Study and Help Others Living with Asthma
This study aims to determine the effectiveness and safety of a new investigational medication, Fluticasone Propionate/Albuterol Sulfate Combination (Fp/ABS eMDPI), in participants suffering from asthma.
Research Studies are required by the FDA in the development of new medications, and upon approval from the FDA assuring patient safety a research study may be conducted. It is only with your participation that new drugs will be available for future generations, improving quality of care and quality of life.
Your privacy is important to us. By completing the following pre-screener you agree to our Privacy Policy and Terms of Use, and agree that we may retain the personal information you provide and share it with personnel involved in the study, or otherwise as described in the Privacy Policy, and we or our affiliates may contact you by phone using automated technology or pre-recorded voicemail or other means including but not limited to text messages (standard messaging rates may apply) regarding research studies.
At Elixia, we are dedicated to advancing medical research and improving lives through innovative clinical studies. Our mission is to develop groundbreaking treatments for respiratory disorders, including asthma, to enhance patient outcomes and improve quality of life.
Join the Study and Help Others Living with Asthma
This study aims to determine the effectiveness and safety of a new investigational medication, Fluticasone Propionate/Albuterol Sulfate Combination (Fp/ABS eMDPI), in participants suffering from asthma.
Research Studies are required by the FDA in the development of new medications, and upon approval from the FDA assuring patient safety a research study may be conducted. It is only with your participation that new drugs will be available for future generations, improving quality of care and quality of life.
Your privacy is important to us. By completing the following pre-screener you agree to our Privacy Policy and Terms of Use, and agree that we may retain the personal information you provide and share it with personnel involved in the study, or otherwise as described in the Privacy Policy, and we or our affiliates may contact you by phone using automated technology or pre-recorded voicemail or other means including but not limited to text messages (standard messaging rates may apply) regarding research studies.